1. Polymerase chain reaction facilitates the cloning, CDR-grafting, and rapid expression of a murine monoclonal antibody directed against the CD18 component of leukocyte integrins
- Author
-
Ming-Fan Law, Irwin I. Singer, Julie A. DeMartino, Bruce L. Daugherty, George E. Mark, and Douglas W. Kawka
- Subjects
Integrins ,medicine.drug_class ,Recombinant Fusion Proteins ,Genetic Vectors ,Molecular Sequence Data ,Gene Expression ,Complementarity determining region ,Molecular cloning ,Biology ,Monoclonal antibody ,Immunoglobulin light chain ,Humanized antibody ,Transfection ,Polymerase Chain Reaction ,law.invention ,Mice ,law ,Antigens, CD ,Genetics ,medicine ,Leukocytes ,Animals ,Humans ,Cloning, Molecular ,Cells, Cultured ,Base Sequence ,Genes, Immunoglobulin ,Antibodies, Monoclonal ,DNA ,Molecular biology ,CD18 Antigens ,biology.protein ,Recombinant DNA ,Immunoglobulin heavy chain ,Immunoglobulin Light Chains ,Binding Sites, Antibody ,Antibody ,Immunoglobulin Heavy Chains - Abstract
Two novel approaches of recombinant PCR technology were employed to graft the complementarity determining regions from a murine monoclonal antibody (mAb) onto human antibody frameworks. One approach relied on the availability of cloned human variable region templates, whereas the other strategy was dependent only on human variable region protein sequence data. The transient expression of recombinant humanized antibody was driven by the adenovirus major late promoter and was detected 48 hrs post-transfection into non-lymphoid mammalian cells. The application of these new approaches enables the expression of a recombinant humanized antibody just 6 weeks after initiating the cDNA cloning of the murine mAb.
- Published
- 1991